Literature DB >> 28596671

Autologous Blood Transfusion as a Life Saving Measure for a Trauma Patient with Fracture Femur and Drug Induced Hemolytic Anemia: A Case Report.

Sumit Vishwakarma1,2, Rahul Chaurasia2, Arulselvi Subramanian1,2, Vivek Trikha3, Kabita Chatterjee2.   

Abstract

A positive direct antiglobulin test has been reported in 1:1000 to 1:14,000 blood donors and 1-15 % of hospital patients. Drugs may cause a positive direct antiglobulin test result and/or immune-mediated haemolysis with an incidence of approximately 1 in a 1 million population. Our aim is to highlight the importance of following strict transfusion protocols and management insight in a direct antiglobulin test positive patient showing incompatibility with multiple units possibly due to drug induced immune haemolytic anaemia (DIIHA). We also aim to highlight importance of autologous blood transfusion in an orthopaedic procedure in which homologous transfusion may be needed. We are presenting case of a 36 year old male with alleged h/o of road traffic accident with comminuted intra-articular fracture of the distal femur. He had h/o of ankylosing spondylitis since last 20 years on medication with indomethacin and methotrexate. A review of the literature was performed which showed use of drug methotrexate as an uncommon clinical entity for DIIHA; sporadic reports exist in the medical literature to support this view. The review of the literature in combination with our own data showed methotrexate can be a cause of DIIHA. We therefore advocate proper immunohaematological work up and use of autologous blood for management of at-risk-patients of DIIHA.

Entities:  

Keywords:  Autologous blood transfusion; DIIHA; Methotrexate

Year:  2016        PMID: 28596671      PMCID: PMC5442060          DOI: 10.1007/s12288-016-0715-6

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  25 in total

1.  [A case of rheumatoid arthritis associated with autoimmune hemolytic anemia due to weekly low-dose methotrexate therapy].

Authors:  K Yoshida; D Kurosaka; Y Ozawa; T Yokoyama; N Tajima
Journal:  Ryumachi       Date:  2000-08

Review 2.  "Least incompatible" units for transfusion in autoimmune hemolytic anemia: should we eliminate this meaningless term? A commentary for clinicians and transfusion medicine professionals.

Authors:  Lawrence D Petz
Journal:  Transfusion       Date:  2003-11       Impact factor: 3.157

3.  An update on drug-induced immune hemolytic anemia.

Authors:  G Garratty; P A Arndt
Journal:  Immunohematology       Date:  2007

4.  Terminology for red cell surface antigens. Makuhari Report.

Authors:  G L Daniels; D J Anstee; J P Cartron; W Dahr; S Henry; P D Issitt; J Jørgensen; W J Judd; L Kornstad; C Levene; C Lomas-Francis; A Lubenko; D Mallory; J M Moulds; J J Moulds; Y Okubo; M Overbeeke; M E Reid; P Rouger; S Seidl; S Sistonen; S Wendel; T Zelinski
Journal:  Vox Sang       Date:  1996       Impact factor: 2.144

5.  Controversies in transfusion medicine. Is autologous blood transfusion worth the cost? Con.

Authors:  J P AuBuchon; J D Birkmeyer
Journal:  Transfusion       Date:  1994-01       Impact factor: 3.157

6.  Transfusing patients with autoimmune haemolytic anaemia.

Authors:  G Garratty; L D Petz
Journal:  Lancet       Date:  1993-05-08       Impact factor: 79.321

7.  One center's experience: the serology and drugs associated with drug-induced immune hemolytic anemia--a new paradigm.

Authors:  Susan T Johnson; Judith T Fueger; Jerome L Gottschall
Journal:  Transfusion       Date:  2007-04       Impact factor: 3.157

8.  Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests.

Authors:  P A Arndt; R M Leger; G Garratty
Journal:  Transfusion       Date:  1999 Nov-Dec       Impact factor: 3.157

Review 9.  A physician's guide to transfusion in autoimmune haemolytic anaemia.

Authors:  Lawrence D Petz
Journal:  Br J Haematol       Date:  2004-03       Impact factor: 6.998

10.  Red blood cell transfusion in warm-type autoimmune haemolytic anaemia.

Authors:  A Salama; H Berghöfer; C Mueller-Eckhardt
Journal:  Lancet       Date:  1992 Dec 19-26       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.